Interest in breast cancer chemoprevention among older women
- 7 June 2007
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 108 (3) , 435-453
Abstract
The study aim is to describe interest in breast cancer chemoprevention among older women without a history of breast cancer and to determine whether aging-related factors such as diminished life expectancy, increasing comorbidity and medication burden attenuate chemoprevention interest. Cross-sectional survey. University of Pennsylvania Health System. Four-hundred fifty-seven community-dwelling women aged 60–65 years old who were potentially eligible for breast cancer chemoprevention according to guidelines linking risk and eligibility to age. Interest in breast cancer chemoprevention, Gail model breast cancer risk, perceived breast cancer risk, breast cancer worry, self-reported health status and comorbidities, and self-reported perceived life expectancy. Of 457 participants, 11.2% reported being interested in taking chemoprevention, 40.9% reported no interest, and 47.9% reported being unsure about their interest in chemoprevention. Overall, interest in chemoprevention was not associated with individual Gail model breast cancer risk. In adjusted analysis, lack of interest among high-risk women was associated with low breast cancer worry and low perceived risk. Conversely, interest in chemoprevention among low risk women was associated with greater breast cancer worry. Age-related factors hypothesized to affect chemoprevention interest, including subjective life expectancy, increased comorbidity, and number of daily medications did not attenuate chemoprevention interest. Breast cancer worry and perceived breast cancer risk contribute to the lack of correlation between interest in breast cancer chemoprevention and objective breast cancer risk. Perceived life expectancy, increased comorbidity, and medication burden do not attenuate chemoprevention interest among older women.Keywords
This publication has 27 references indexed in Scilit:
- Older adults' attitudes about continuing cancer screening later in life: a pilot study interviewing residents of two continuing care communitiesBMC Geriatrics, 2006
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 TrialJAMA, 2006
- Older adults' beliefs about physician-estimated life expectancy: a cross-sectional surveyBMC Family Practice, 2006
- The Influence of Health Status, Age, and Race on Screening Mammography in Elderly WomenArchives of internal medicine (1960), 2005
- Chemoprevention of Breast Cancer: A Summary of the Evidence for the U.S. Preventive Services Task ForceAnnals of Internal Medicine, 2002
- Women's Interest in Chemoprevention for Breast CancerArchives of internal medicine (1960), 2001
- Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast CancerJNCI: Journal of the National Cancer Institute, 1999
- American Society of Clinical Oncology Technology Assessment on Breast Cancer Risk Reduction Strategies: Tamoxifen and RaloxifeneJournal of Clinical Oncology, 1999
- Perception of breast cancer risk among women in breast center and primary care settings: Correlation with age and family history of breast cancerSurgery, 1996
- Perceptions of Breast Cancer Risk and Screening Effectiveness in Women Younger Than 50 Years of AgeJNCI: Journal of the National Cancer Institute, 1995